All-trans retinoic acid and 1α,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes

Leukemia

Volumn 8, Issue 5, 1994, Pages 806-815

  Brown, Geoffrey ^a   Bunce, Christopher M ^a   Rowlands, David C ^a   Williams, Graham R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 0028318182     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Collins S, Gallo R, Gallagher R. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977;270:347-349.
2. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzler R, Aulakh G, Ting M, Ruscetti F, Gallo R. Characterisation of the continuous differentiating cell line (HL60) from a patient with acute promyelocytic leukemia. Blood 1979;54:713-733.
3. Collins SJ. The HL60 promeyelocytic leukaemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 1987;70:1233-1244.
4. Birnie GG. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br J Can 1988;589:41-45.
5. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promeylocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980;77:2936-2940.
6. Sakashita A, Nakamaki T, Tsuruoka N, Honma Y, Hozumi M. Granulocyte colony-stimulating factor not granulocyte-macrophage-colony stimulating factor co-operates with retinoic acid in the induction of functional n-formyl-methionyl-phenylalanine receptors in HL60 cells. Leukemia 1991;5:26-31.
7. Olsson IL, Breitman TR, Gallo RC. Priming of human myeloid leukemic cell lines HL60 and U937 with retinoic acid for differentiation effects of cyclic adenosine 3′,5′-monophosphate inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res 1982;42:3928-3933.
8. Degos L. Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy. Curr Opin Oncol 1992;4:45-52.
9. Paquette RL, Koeffler HP. Differentiation therapy. Hematol Oncol Clin North Am 1992;6:687-706.
10. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreef M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New Engl J Med 1991;324:1385-1393.
11. 3 and its fluorinated analogues. Cancer Res 1984;44:5624-5628.
12. 3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leukemia Res 1983;7:51-55.
13. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T. 1a, 25 Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL60). Biochem J 1982;204:713-719.
14. Munker R, Norman A, Koeffler HP. Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 1986;78:424-430.
15. Cornic M, Delva L, Guidez F, Balitrand N, Degos L, Chomienne C. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic patients. Cancer Res 1992;52:3329-3334.
16. Bike DD. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocrine Rev 1992;13: 765-782.
17. 3 analogues with potent effects on cell growth regulation and immune responses: structure-activity studies. In: Norman AW, Bouilon R, Thomasset M, eds. Vitamin D: gene regulation, structure-function analysis and clinical application: proceedings of the 8th workshop on vitamin D. Berlin: de Gruyter, 1991:478-485.
18. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
19. Williams GR, Brent GA. Specificity of nuclear hormone receptor action: who conducts the orchestra? J Endocrinol 1992; 135:191-194.
20. Green S. Promiscuous liaisons. Nature 1993;361:590-591
21. 3 analogies: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991;42:1569-1575.
22. Samuels HH, Tsai JS. Thyroid hormone action: demonstration of similar receptors in isolated nuclei of rat liver and cultured GH4 cells. J Clin Invest 1974;53:656-659.
23. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
24. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 1984;133:1710-1715.
25. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD. Immunobiochemical and molecular biologic characterisation of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873.
26. Toksoz D, Bunce CM, Stone PCW, Michell RH, Brown G. Variant cell lines from the human promyelocyte line HL60 Leuk Res 1982;6:491-498.
27. Sobel A, Boutterin M-C, Beretta L, Chneiweiss H, Doye V, Peyro-Saint-Paul H. Intracellular substrates for extracellular signalling J Biol Chem 1989;264:3765-3772.
28. Braverman R, Bhattacharya B, Feuerstein N, Cooper HL. Identification and characterisation of the nonphosphorylated precursor of pp17, a phosphoprotein associated with phorbol ester induction of growth arrest and monocyte differentiation in HL60 promyelocytic leukemia cells. J Biol Chem 1986;261:14342-14348.
29. Gullberg M, Noreus K, Brattsand G, Friedrich B, Shingler V. Purification and characterisation of a 19-kilodalton intracellular protein. J Biol Chem 1990;265:17499-17505.
30. Zhu X-X, Kozarsky K, Strahler JR, Eckerskorn C, Lottspeich F, Melham R, Lowe J, Fox DA, Hanash SM, Atweh GF. Molecular cloning of a novel leukemia-associated gene. J Biol Chem 1989;264:14556-14560.
31. Hailat N, Strahler J, Melham R, Zhu X-X, Brodeur G, Seeger RC, Reynolds CP, Hanash SM. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (op18). Oncogene 1990;5:1615-1618.
32. Melham RF, Strahler JR, Hailat N, Zhu X-X. Brodeur G, Hanash SM. Involvement of Op18 in cell proliferation. Biochem Biophys Res Comm 1991;179:1649-1655.
33. Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nanberg E, Sideras P, Gullberg M. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (Oncoprotein 18) in normal and neoplastic cells Leukemia 1993;7:569-579.
34. Koppel J, Bouterrin MC, Doye V, Peyro-Saint-Paul H, Sobel A. Developmental tissue expression and phylogenetic conservation of stathmin, a phosphoprotein associated with cell regulations. J Biol Chem 1990;265:3703-3707.
35. Yam LT, Li CY, Cosby WW. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971;55:283-290.
36. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax embedded sections with the antibody MIB1. Histopathology 1993;22:355-360.
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 1987;162:156-159.
38. Aususbel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology. 2 vols New York: John Wiley, 1987.
39. Zelent A, Krust A, Petkovich M, Kastner P, Chambon P. Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 1989;339:714-717.
40. Baker AR, McDonnell DP, Hughes M, Crisp TM, MAngelsdorf DJ, Haussler MR, Wesley Pike J, Shine J, O'Malley BW. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988;85:3294-3298.
41. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway Nature 1990;345:224-229.
42. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterisation of three RXR genes that mediate the action of 9-cis retinoic acid Genes Dev 1992;6:329-344.
43. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocrine Rev 1992;13:719-764.
44. Largman C, Detmer K, Corral JC, Hack FM, Lawrence HJ. Expression of retinoic acid receptor alpha mRNA in human leukemia cells. Blood 1989;74:99-102.
45. de The H, Marchio A, Tiollais P, Dejean A. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. EMBO J 1989;8:429-433.
46. Ishikawa T, Umesono K, Mangelsdorf DJ, Aburatani H, Stanger BZ, Shibasaki Y, Imawari M, Evans RM, Takaku F. A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol Endocrinol 1990;4:837-844.
47. 3 on the differentiation of the human monocytic cell line U937 Leuk Res 1991;15:1145-1152.
48. O'Malley BW. The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol 1990;4:363-369.
49. O'Malley BW, Coneely OM. Orphan receptors: in search of a unifying hypothesis for activation. Mol Endocrinol 1992;6:1359-1361.
50. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J-Y, Staub A, Garnier J-M, Mader S, Chambon P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992;68:377-395.
51. 3 signalling. Nature 1992;355:446-449.
52. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin J-M, Glass CK, Rosenfeld MG. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-1266.
53. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG. RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors EMBO J 1992,11:1409-1418.
54. Zhang X-K, Hoffmann B, Tran PBV, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992;355:441-446.
55. Lazar MA, Berrodin TJ, Harding HP. Differential DNA binding by monomeric, homodimeric, and potentially heterodimeric forms of the thyroid hormone receptor. Mol Cell Biol 1991;11:5005-5015.
56. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH. Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers Mol Endocrinol 1992;6:429-442.
57. Aneskievich BJ, Fuchs E. Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements. Mol Cell Biol 1992;12:4862-4871.
58. Schroeder C, Gibson L, Zenke M, Beug H. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erb A oncogene action. Oncogene 1992:7:217-227.
59. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978;15:393-403.
60. Tabin CJ. Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell 1991;66:199-217.
61. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988;37:889-895.
62. Binderup L, Kragballe K. Origin of the use of calcipotriol in psoriasis treatment. Rev Contemp Pharmacother 1992;3:357-365.
63. Sone T, Kerner S, Pike JW. Vitamin D receptor interaction with specific DNA. J Biol Chem 1991;266:23296-23305.
64. Markose ER, Stein JL, Stein GS, Lian JB. Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 1990;87:1701-1705.
65. Yen PM, Darling DS, Carter RL, Forgione M, Umeda PK, Chin WW. Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. J Biol Chem 1992;267:3565-3568.
66. Brown G, Bunce CM, Howie AJ, Lord JM. Stochastic or ordered lineage commitment during hemopoiesis? Leukemia 1987; 1:150-153.
67. Brown G, Bunce CM, Lord JM, McConnell FM. The development of cell lineages: a sequential model. Differentiation 1988; 39:83-89.